These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 32871777)
21. Circular RNA Hsa_Circ_0091579 Serves as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma. Zhang C; Zhang C; Lin J; Wang H Cell Physiol Biochem; 2018; 51(1):290-300. PubMed ID: 30453307 [TBL] [Abstract][Full Text] [Related]
22. Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma. Lee NP; Tsang FH; Shek FH; Mao M; Dai H; Zhang C; Dong S; Guan XY; Poon RT; Luk JM Int J Cancer; 2010 Aug; 127(4):968-76. PubMed ID: 19998337 [TBL] [Abstract][Full Text] [Related]
23. Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma. Li YC; Wang D; Zhu GY Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4855-4860. PubMed ID: 30070318 [TBL] [Abstract][Full Text] [Related]
24. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data. Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866 [TBL] [Abstract][Full Text] [Related]
25. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma. Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471 [TBL] [Abstract][Full Text] [Related]
26. Roles of the miR-139-5p/CCT5 axis in hepatocellular carcinoma: a bioinformatic analysis. Xu J; Zhang Y; Liu C; Yan P; Yang Z Int J Med Sci; 2021; 18(15):3556-3564. PubMed ID: 34522182 [No Abstract] [Full Text] [Related]
27. A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma. Tang H; You T; Sun Z; Bai C BMC Cancer; 2022 Feb; 22(1):197. PubMed ID: 35189839 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma. Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704 [TBL] [Abstract][Full Text] [Related]
29. Prognostic and Clinical Implications of WNK Lysine Deficient Protein Kinase 1 Expression in Patients With Hepatocellular Carcinoma. Ho YJ; Chang J; Yeh KT; Gong Z; Lin YM; Lu JW In Vivo; 2020; 34(5):2631-2640. PubMed ID: 32871793 [TBL] [Abstract][Full Text] [Related]
30. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma. Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005 [No Abstract] [Full Text] [Related]
31. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma. Li M; Luo RZ; Chen JW; Cao Y; Lu JB; He JH; Wu QL; Cai MY J Transl Med; 2011 Jan; 9():5. PubMed ID: 21205329 [TBL] [Abstract][Full Text] [Related]
32. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population. Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136 [TBL] [Abstract][Full Text] [Related]
33. Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase. Martineau Y; Wang X; Alain T; Petroulakis E; Shahbazian D; Fabre B; Bousquet-Dubouch MP; Monsarrat B; Pyronnet S; Sonenberg N Mol Cell Biol; 2014 Mar; 34(6):1046-53. PubMed ID: 24396066 [TBL] [Abstract][Full Text] [Related]
34. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma. He D; Liao S; Cai L; Huang W; Xie X; You M BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705 [TBL] [Abstract][Full Text] [Related]
35. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma. Ma X; Ding Y; Zeng L BMC Cancer; 2021 Apr; 21(1):418. PubMed ID: 33858382 [TBL] [Abstract][Full Text] [Related]
36. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546 [TBL] [Abstract][Full Text] [Related]
37. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma. Wu MT; He SY; Chen SL; Li LF; He ZQ; Zhu YY; He X; Chen H BMC Cancer; 2019 Jun; 19(1):538. PubMed ID: 31164099 [TBL] [Abstract][Full Text] [Related]
38. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma. Chen L; Jiang M; Yuan W; Tang H J Invest Surg; 2012 Jun; 25(3):156-61. PubMed ID: 22583011 [TBL] [Abstract][Full Text] [Related]
39. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma. Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157 [TBL] [Abstract][Full Text] [Related]
40. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance. Yang L; Xu Q; Xie H; Gu G; Jiang J Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]